- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07032805
- Original Trial
Study on Personalized Total Knee Arthroplasty (TKA) Rehabilitation Using Telemedicine and Psychoeducation (TKA)
Coping to Move Again: The Psychological Dimension of Tele-Supported Rehabilitation After Knee Arthroplasty - A Randomized Controlled Trial
Study Overview
Status
Conditions
Detailed Description
To ensure quality and ethical standards in the design and implementation of our randomized clinical trial (RCT), we will apply the Helsinki criteria and the CONSORT checklist. All patients hospitalized for rehabilitation after total knee arthroplasty (TKA) at the San Giovanni di Dio Rehabilitation Center in Adelfia (BA) will be evaluated for eligibility to participate in a clinical study on primary symptomatic osteoarthritis (OA) of the knee between July and October 2025.Inclusion criteria (in addition to those already mentioned in the brief summary): •Ability to stand on one leg. Exclusion criteria: •Post-traumatic or inflammatory knee OA; •Valgus/varus deformity (hip-knee-ankle angle > or < 10°).The control group and the study group, after medical, physiotherapeutic, and psychological assessment, will receive a treatment focused on strengthening lower limb muscles, improving joint range of motion, enhancing balance, and gait training. This will be delivered in two physiotherapy sessions per day, each lasting 45 minutes, during the 22-25 days of hospitalization. Following discharge, participants will receive outpatient treatment consisting of two 45-minute sessions per week for three months at a physiotherapy clinic. The control group will follow this program as usual, while the study group will have the same program reinforced with home supervision via telemedicine. A physiotherapist, trained on the initial psychological assessments, will conduct teleconsultations using Zoom (with end-to-end encryption). Patient characteristics and outcome measures will be reported in aggregate form, as mean ± standard deviation for continuous variables and absolute frequencies (percentages) for categorical variables. Statistical analysis of outcomes will include testing the significance of differences. The two groups will be compared based on baseline characteristics and changes in outcomes. Data Profile: Since variables are non-normally distributed (Shapiro-Wilk test), the study uses non-parametric methods. Data is expressed as medians (IQR) or frequencies (%).
Baseline Comparisons: Groups are compared via the Mann-Whitney U test (continuous) and χ 2 or Fisher's exact tests (categorical). Longitudinal Analysis: Clinical outcomes over time (T0-T2) are evaluated using a non-parametric mixed-effects model to analyze time, group, and their interaction. Changes & Correlations: Relative variation is calculated as Δ=(T 2-T0)/T0. Its relationship with baseline psychological scores is assessed via Spearman's correlation. Thresholds: Analyses are performed in R (v4.2), using a significance threshold of p<0.05.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Bari
-
Adelfia, Bari, Italy, 70071
- Presidio territoriale di recupero e riabilitazione funzionale "San Giovanni di Dio" Conssi welfare
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Recent unilateral total knee arthroplasty;
- Body Mass Index (BMI) < 35;
- Ability to stand on one leg;
- Absence of active known neurological or oncological diseases.
Exclusion Criteria:
- Post-traumatic or inflammatory knee osteoarthritis (OA);
- Valgus/varus deformity (hip-knee-ankle angle > or < 10°).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: outpatient rehabilitative treatment plus tele-rehabilitation
The study group will undergo medical, physiotherapeutic, and psychological assessment.
They will then receive a treatment focused on strengthening lower limb muscles, improving joint range of motion, enhancing balance, and developing walking ability.
This will be delivered in two daily physiotherapy sessions, each lasting 45 minutes, over the 22-25 days of hospitalization.
After discharge, they will continue outpatient treatment with two 45-minute sessions per week for three months at a physiotherapy clinic.
Additionally, they will receive home supervision from a physiotherapist via telemedicine (video calls using Zoom with encryption), trained on the patient's initial issues identified through psychological evaluation.
|
personalized outpatients rehabilitation treatment after TKA, including psychomotivational framing, and telemedicine-based rehabilitation interventions
|
|
Active Comparator: Standard outpatient rehabilitative treatment
The control group will undergo medical, physiotherapeutic, and psychological assessments.
They will then receive treatment focused on strengthening lower limb muscles, improving joint range of motion, enhancing balance, and gait training.
This will be administered in two physiotherapy sessions per day, each lasting 45 minutes, over the 22-25 days of hospitalization.
After discharge, they will continue with outpatient physiotherapy consisting of two 45-minute sessions per week for three months at an outpatient physiotherapy clinic.
|
standard outpatient rehabilitation treatment after TKA
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
VAS (Pain assessment)
Time Frame: At baseline (T0), at 1.5 months (T1), and at 3 months (T2)
|
We will use the VAS (Visual Analogue Scale) to quickly and reliably determine the pain perceived by the patient.
The VAS (Visual Analogue Scale) consists of a horizontal line 10 centimeters long, with two endpoints representing opposite levels of sensation.
Zero is at the extreme left, indicating "No pain," and ten is at the extreme right, representing "The worst pain imaginable."
The patient subjectively expresses their perception of pain by indicating a point on the line.
|
At baseline (T0), at 1.5 months (T1), and at 3 months (T2)
|
|
Western Ontario and McMaster Universities Arthritis Index (Physical function)
Time Frame: At baseline (T0), at 1.5 months (T1), and at 3 months (T2)
|
The Western Ontario and McMaster Universities Arthritis Index (WOMAC) is a patient-reported outcome questionnaire that assesses symptoms and activity limitations in osteoarthritis or following joint replacement surgery.
It evaluates the severity of pain, joint stiffness, and physical function with 24 questions, each using a Likert scale ranging from 0 (no symptoms) to 4 (high intensity or difficulty);
|
At baseline (T0), at 1.5 months (T1), and at 3 months (T2)
|
|
Knee Injury and Osteoarthritis Outcome Score (Knee function)
Time Frame: At baseline (T0), at 1.5 months (T1), and at 3 months (T2)
|
The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a self-administered questionnaire that assesses symptoms related to the knee joint in osteoarthritis and after total knee replacement surgery.
The scale consists of 42 items that evaluate symptoms, pain, daily life functions and activities, sports and recreational activities, and quality of life related to the knee.
Responses are on a 5-point Likert scale ranging from 0 (no problems or difficulties) to 4 (severe problems or difficulties).
|
At baseline (T0), at 1.5 months (T1), and at 3 months (T2)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Barthel Index (Activities of daily living)
Time Frame: At baseline (T0), at 1.5 months (T1), and at 3 months (T2)
|
The Barthel Index (BI) for Activities of Daily Living is an ordinal scale that measures a person's ability to perform daily activities through 10 items.
Each item is rated by the evaluator based on the individual's capacity to complete the task independently, with assistance, or not at all, with scores as follows:0=unable, 1=needs assistance, 2=independent.
The total scores are on a scale from 0 to 100.
Interpretation of dependency levels: 0 to 20: Total dependence/21 to 60:Severe dependence/61 to 90:Moderate dependence/91 to 99:Slight dependence.
|
At baseline (T0), at 1.5 months (T1), and at 3 months (T2)
|
|
Modified Rankin Scale (Degree of disability in daily activities)
Time Frame: At baseline (T0), at 1.5 months (T1), and at 3 months (T2)
|
The Modified Rankin Scale (mRS) measures the degree of disability, scored from 0 to 6: 0:No symptoms/1:No significant disability despite symptoms/2:Slight disability; unable to perform all previous activities but able to manage own affairs without assistance/3:Moderate disability; requires some help but can walk without assistance/4:Moderately severe disability/5:bedridden, incontinent, and requiring constant care and assistance/6: Dead
|
At baseline (T0), at 1.5 months (T1), and at 3 months (T2)
|
|
Credibility/Expectancy Questionnaire (psychological and behavioral assessment)
Time Frame: At baseline (T0)
|
The Credibility/Expectancy Questionnaire(CEQ)measures treatment expectancy and the credibility.It assesses two aspects:cognitive aspects as the reliability of the treatment and emotional aspects, as the belief in improvement related to the treatment.
|
At baseline (T0)
|
|
COPing Orientation to Problems Experienced-Italian Version (Assessment of coping styles)
Time Frame: At baseline (T0)
|
The COPing Orientation to Problems Experienced-Italian Version(COP-NIV)explores five main independent dimensions.
It consists of 60 items assessing how individuals react to stressful events, rated on a 4point scale
|
At baseline (T0)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Analgesia
Time Frame: At 1.5 months (T1) and at 3 months (T2)
|
Each patient must complete a diary in which they will record their daily consumption of any analgesic medications taken for knee pain throughout the study period, from start to finish.
They will report the total consumption weekly and monthly (over 12 weeks / 3 months) and specify the type of medication (paracetamol/NSAIDs/corticosteroids/opioids/muscle relaxants).
|
At 1.5 months (T1) and at 3 months (T2)
|
|
Abandonment of mobility aids
Time Frame: At 1.5 months (T1) and at 3 months (T2)
|
the complete discontinuation of any prescribed mobility aids will be documented.
|
At 1.5 months (T1) and at 3 months (T2)
|
|
Demographic indicators
Time Frame: At baseline (T0)
|
age, gender, education level, marital status, employment status, presence of a caregiver
|
At baseline (T0)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Marisa Megna, Professor, University Bari "A. Moro"
- Study Director: Teresa Paolucci, Research, University of Chieti-Pescara "G. D'Annunzio"
- Principal Investigator: Laura B Rizzo, MD, University of Bari "A. Moro"
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Prot.2114/CEL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arthrosis of the Knee
-
Rigshospitalet, DenmarkZimmer BiometActive, not recruiting
-
Edin MešanovićCompletedOsteoarthritis | Osteoarthritis of the Knee | Osteoarthritis of Knee | Osteoarthritis of the Knees | Osteoarthritis (OA) of the Knee | Osteoarthritis Knee | Osteoarthritis in the Knee | Osteoarthritis of Knee JointBosnia and Herzegovina
-
University of Eastern FinlandKuopio University HospitalCompletedHip Arthrosis | Multimorbidity | Knee ArthrosisFinland
-
Stryker Trauma GmbHUnknownAvascular Necrosis of the Head of Humerus | Post-traumatic Arthrosis of Other Joints, Shoulder Region | Localized, Primary Osteoarthritis
-
University Hospital, GhentRecruiting
-
Orthopaedische Klinik Koenig-Ludwig-HausUnknown
-
Feza Korkusuz MDDr. Özgür Oktay Nar Private Clinic, Bursa, Türkiye; Contura International A... and other collaboratorsCompletedOsteoarthritis | Knee Osteoarthritis | Osteoarthritis of the Knee | Degenerative Joint Disease of the KneeTurkey (Türkiye)
-
Stryker Trauma GmbHUnknownAvascular Necrosis of the Head of Humerus | Post-traumatic Arthrosis of Other Joints, Shoulder Region | Localized, Primary Osteoarthritis
-
Wu zenanThe Affiliated Hospital of Jiangxi University of Traditional Chinese MedicineRecruitingOsteoarthritis | Osteoarthritis of the Knees | Osteoarthritis (OA) of the KneeChina
-
Hillerod Hospital, DenmarkZimmer BiometCompleted
Clinical Trials on standard outpatient rehabilitation treatment after TKA
-
Kinex Medical Company, LLCHealth Factors IncActive, not recruitingOsteoarthritis, KneeUnited States
-
Istituto Ortopedico RizzoliRecruiting
-
University of AarhusWithdrawn
-
Hartcentrum HasseltTerminatedQuality of Life | Pain | Respiratory Depression | Mechanical Complication of Coronary Artery Bypass GraftBelgium
-
University of RzeszowCompleted
-
University of RochesterArnold VenturesCompletedSchizophrenia | Bipolar Disorder | Criminal BehaviorUnited States
-
Region SkaneLund University; Swedish University of Agricultural Sciences; Epidemiology and...Completed
-
Nova Scotia Health AuthorityCompletedEating DisordersCanada
-
University Hospital Inselspital, BerneSchweizerische HerzstiftungCompletedStroke | Cerebrovascular Disorders | PreventionSwitzerland
-
Azienda Unita' Sanitaria Locale Di ModenaAzienda Unita Sanitaria Locale Reggio Emilia; University of Modena and Reggio... and other collaboratorsCompletedAmyotrophic Lateral SclerosisItaly